[Event Report] The Second Advisory Board Meeting of the Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society (February 22, 2022)
date : 3/7/2022
Tags: NCDs, Precision Cancer Medicine
Health and Global Policy Institute (HGPI)/NCD Alliance Japan held the Second Advisory Board Meeting of the “Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society.” To avoid the potential spread of Coronavirus Disease 2019 (COVID-19), the meeting was held in a fully remote format and was closed to the public.
At the meeting, participants discussed the directions of solutions for the five discussion points identified at the first advisory board meeting (held December 14, 2021), which are listed below.
- Equity in the healthcare provision system and in access
- Building patient awareness and mechanisms for solving Ethical, Legal, and Social Issues (ELSI) and expanding Patient and Public Involvement (PPI)
- Assessment methods suitable for precision medicine
- Building systems for promoting R&D and making effective use of evidence
- Limits on the number of times insurance coverage is granted, limits on the timing for insurance coverage, and how to best provide testing and treatment
Moving forward, we will draft and publicize policy recommendations based on the discussions held at the first and second advisory board meetings as well as on the multifaceted opinions we gathered from multi-stakeholders from industry, Government, academia, and civil society during individual hearings. These efforts will be advanced mainly at HGPI.
■ Event overview
Date and time: Tuesday, February 22, 2022; from 13:00 to 15:00
Venue: Online using the Zoom conferencing system
Host: Health and Global Policy Institute (HGPI)
■ Second Advisory Board Meeting participants (Titles omitted; in no particular order)
Ataru Igarashi (Associate Professor, Unit of Public health and Preventive Medicine, Yokohama City University School of Medicine)
Mitsuho Imai (Project Assistant Professor, Shinanomachi Cancer Center, School of Medicine, Keio University)
Hiroji Iwata (Vice Director and Chief, Department of Breast Oncology, Aichi Cancer Center Hospital)
Atsushi Otsu (Director, National Cancer Center Hospital East)
Shinji Kosugi (Professor, Medical Ethics and Medical Genetics, Department of Social Medicine, Graduate School of Medicine and Faculty of Medicine, Kyoto University)
Naomi Sakurai (President, Cancer Solutions Co., Ltd)
Kuniko Sunami (Department of Laboratory Medicine, National Cancer Center Hospital)
Kazuo Hasegawa (Representative, NPO Lung Cancer Patient Association One Step)
Yoshiyuki Majima (Chairman, NPO PanCAN Japan)
Tetsuya Mitsutomi (Professor/Senior Staff, Division of Thoracic Surgery, School of Medicine, Kindai University)
Takayuki Yoshino (Director, Department of Gastrointestinal Oncology, National Cancer Center Hospital East)
Reiko Akizuki (Director, Oncology Department, Medical Affairs Division, Janssen Pharmaceutical K.K.)
Kosuke Iijima (Head, Foundation Medicine Business Department, Chugai Pharmaceutical Co., Ltd.)
Sotaro Enatsu (General Manager, Oncology Business Unit, Research and Development and Medical Affairs, Eli Lilly Japan K.K.)
Junpei Soeda (Head, Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited)
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)